Ovid Therapeutics Inc (NASDAQ:OVID)

Delayed Data
As of Mar 23
 +0.06 / +2.48%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Ovid Therapeutics Inc have a median target of 4.75, with a high estimate of 7.00 and a low estimate of 2.50. The median estimate represents a +90.00% increase from the last price of 2.50.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Ovid Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -6.99%
Growthannually 7.02%


Growthquarterly -59.67%
Growthannually -95.26%
Key to the earnings and sales forecast charts.